Development and Validation of an HPTLC - Densitometric Method for Determination of Levodopa in Seeds of Mucuna Pruriens and Its Dosage Form
 
More details
Hide details
1
Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Siksha O Anusandhan University, Ghatikia, Bharatpur, Bhubaneswar - 750003, Orissa, India
2
Pharmaceutical Analysis and Quality Assurance division, College of pharmaceutical Sciences, Andhra University, Visakhapatnam-530003, Andhra Pradesh, India
Publish date: 2017-10-27
 
Eurasian J Anal Chem 2010;5(2):126–136
KEYWORDS:
ABSTRACT:
A simple, sensitive, selective HPTLC - densitometric method was developed and validated for the determination of Levodopa in seeds of Mucuna pruriens and its herbal dosage form. Analysis of Levodopa was carried out on TLC plates pre-coated with silica gel 60F254 as stationary phase. Linear ascending development of the plate was done in a pre-saturated twin trough glass chamber. The mobile phase consisted of n-butanol – glacial acetic acid – water (5:1:4, v/v/v) at room temperature (25 ± 2º C). Camag TLC scanner III was used for spectrodensitometric scanning and analysis was done in absorption mode at 280nm. The system gave compact spot for Levodopa (Rf value of 0.39 ± 0.04). The polynomial regression analysis data for the calibration plots showed correlation coefficient r = 0.999 in concentration range 100 – 1000 ng/ spot with respect to peak area. According to International Conference on Harmonization (ICH) guidelines, the method was validated for precision, recovery, robustness and ruggedness. The limits of detection and quantification were determined. The statistical data analysis showed that the method is reproducible and selective for estimation of Levodopa.
CORRESPONDING AUTHOR:
Anindita Behera   
Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Siksha O Anusandhan University, Ghatikia, Bharatpur, Bhubaneswar - 750003, Orissa, India
 
REFERENCES (33):
1. Anonymous (1962) The Wealth of India, PID: CSIR, New Delhi, p. 439.
2. Vaidya A B, Rajgopalan T G, Mankodi N A, Antarkar D S, Tathed P S, Purohit A V, Wadia N H (1978) Treatment of Parkinson's disease with the cowhage plant-Mucuna pruriens Bak.. Neurol. India 26: 171.
3. Hussain G, Manyam B V (1997) Mucuna pruriens proves more effective than LDOPA in Parkinson's disease animal model. Phytother. Res. 11: 419.
4. Nagashayana N, Sankarankutty P, Nampoothiri M R, Mohan P K, Mohankumar K P (2000) Association of L-DOPA with recovery following ayurveda medication in Parkinson’s disease. J. Neurol. Sci. 176: 124.
5. Manyam B V, Dhansekaran M, Hare T A (2004) Effect of antiparkinsonian drug HP - 200 (M. pruriens) on the central monoaminergic neurotransmitters. Phytother. Res. 18: 97.
6. Katzenschlager R, Evans A, Manson A, Patsalos P N, Ratnaraj N, Watt H, Timmermann L, Van der Giessen R, Lees A J (2004) Mucuna pruriens in Parkinson’s disease; a double blind clinical and pharmacological study. J. Neurol. Neurosurgery and Psychiatry. 75: 1672.
7. Amin K M Y, Zillur R S, Khan M N (1996) Sexual function improving effect of Mucuna pruriens in sexually normal male rat. Fitoterapia. 67: 53.
8. Kumar K V A, Srinivas K K, Shanbhag T, Rao S G (1994) Aphrodisiac activity of the seeds of Mucuna pruriens. Indian Drugs. 31: 321.
9. Grover J K, Yadav S, Vats V (2002) Medicinal plants of India with Antidiabetic potential. J. Ethnopharmacol. 81: 81.
10. Akhtar M S, Quereshi A Q, Iqbar J (1990) Antidiabetic evaluation of Mucuna pruriens Linn. seeds. J. Pak. Med. Assoc. 40: 147.
11. Kar A, Choudhary B K , Bandopadhyay N G (2003) Comparative evaluation of hypoglycaemic activity of some Indian medicinal plants in alloxan diabetic rats. J. Ethnopharmacol. 84: 105.
12. Rathi S S , Grover J K, Vats V (2002) The effect of Momordica charantia and Mucuna pruriens in experimental diabetes and their effect on key metabolic enzymes involved in carbohydrate metabolism. Phytother. Res.16: 236.
13. Donati D, Lampariello L R, Pagani R, Guerranti R, Cinci G, Marinello E (2005) Antidiabetic oligocyclitols in seeds of Mucuna pruriens. Phytother. Res. 19: 1057.
14. Pant M C, Uddin I, Bhardwaj U R, Tiwari R D (1968) Blood sugar and total cholesterol lowering effect of Glycine soja (Sieb and Zucc.), Mucuna pruriens (D.C.) and Dolichos biflorus (Linn.) seed diets in normal fasting albino rats. Ind. J.Med. Res. 56: 1808.
15. Rajeshwar Y, Gupta M , Mazumdar U K (2005) Antitumor activity and in vivo status of Mucuna pruriens seeds against Ehrlich Ascites Carcinoma in swiss albino mice. Iranian Journal of Pharmacology and Therapeutics. 4: 46.
16. TripathyY B, Upadhyay A K (2001) Antioxidant property of Mucuna pruriens Linn. Curr. Sci. 80:1377.
17. Tripathy Y B, Upadhyay A K (2002) Effect of the alcohol extract of the seeds of Mucuna pruriens on free radicals and oxidative stress in albino rats. Phytother. Res. 16: 534.
18. Rajeshwar Y, Gupta M, Mazumder U K (2005) Invitro lipid peroxidation and antimicrobial activity of Mucuna pruriens seeds. Iranian Journal of Pharmacology and Therapeutics. 4: 32.
19. Manyam B V, Dhansekaran M, Hare T A (2004) Neuroprotective effects of antiparkinsonian drug Mucuna pruriens. Phytother. Res. 18: 706.
20. Poornachandra M N, Khanum S, Shivanada B G, Shivanada T N, Dris R (2005) Mucuna pruriens (L) DC - A novel drug for learning and memory retrieval. J. Food. Agr. Env. 3: 13.
21. Guerranti R , Aquiyi J C, Errico E, Pagani R, Marinello E (2001) Effects of Mucuna pruriens extract on activation of prothrombin by Echis carinatus venom . J. Ethnopharmacol. 75:175.
22. Guerranti R, Aquiyi J C, Ogueli I G, Onorati G, Neri S, Rosati F, Del Buono F, Lampariello R, Pagani R, Marinello E (2004) Protection of Mucuna pruriens seeds against Echis carinatus venom is exerted through a multiform glycoprotein whose oligosaccharide chains are functional in this role. Biochem. Biophys. Res. Commun. 323: 484.
23. Hishikar R, Shatry S, Shinde S, Gupta S S (1981) Preliminary phytochemical and antiinflammatory activity of seeds of Mucuna pruriens. Ind. J. Pharmacol. 13: 97.
24. Ghosal S, Singh S, Bhattacharya S K (1971) Alkaloids of Mucuna pruriens -- chemistry and pharmacology. Planta Med. 19: 279.
25. Mehta J C, Majumdar D N (1994) Indian Medicinal Plants-V. Mucuna pruriens bark (N.O.: Papilionaceae). Ind. J. Pharm. 6: 92.
26. British Pharmacopoeia (1980) Vol I and II, HMSO Publication Center, London, p.254, 535, 781.
27. The United State Pharmacopoeia (1987) XXI, 21st Revision, The US Pharmaceutical Convention Inc. Rockville, p.585.
28. Parikh K M, Doshi V J, Sawant S V, Salunkhe U B (1990) Estimation of L-DOPA from plant Mucuna pruriens and its formulation. Indian Drugs. 27: 353.
29. Siddhuraju P, Becker K (2001) Rapid reversed-phase high performance liquid chromatographic method for the quantification of L-Dopa (L-3,4- dihydroxyphenylalanine), non-methylated and methylated tetrahydroisoquinoline compounds from Mucuna beans. Food. Chem. 72: 389.
30. Mennickent S, Nail M, Vega M , Diego M (2007) Quantitative determination of LDOPA in tablets by high performance thin layer chromatography. J.Sep.Sci. 30: 1893.
31. Modi K P, Patel N M, Goyal R K (2008) Estimation of L-Dopa from Mucuna pruriens LINN and Formulations Containing M. pruriens by HPTLC Method. Chem. Pharm. Bull. 56: 357.
32. International Conference on Harmonization Specifications (2005) Q2A (R1): Validation of Analytical Procedures: Text and Methodology Test, November 5-10, Chicago, USA.
33. Ujikawa K (1998) Extraction and purification of 3 - (3-4-dihydroxyphenyl) alanine from the seeds of Stizolobium aterrima. Revista Portuguesa de Farmácia. 48: 23.
eISSN:1306-3057